tci Medicare Compliance & Reimbursement - 2005 Issue 22
Pharmaceuticals: CAP Shouldn't Require Exact Date Of Drug Admin
Subscribe or sign in to view the full article.
Article Overview
This article covers stakeholder comments on Medicare’s Competitive Acquisition Program for Part B drugs and the administrative changes it introduces for physician practices. It is relevant to physicians, oncology practices, medical billers, and coding/reimbursement staff who follow CMS drug payment policy and practice workflow issues. The discussion focuses on program structure, billing window changes, vendor participation, and drug ordering and administration logistics without providing coding instructions.
Why This Topic Matters
Understanding policy and workflow changes in Part B drug acquisition and billing helps practices anticipate administrative burden, vendor-related constraints, and scheduling impacts tied to Medicare reimbursement rules.
What You Will Learn
- How physician groups are responding to changes in Medicare drug acquisition policy
- What types of operational and administrative concerns are being raised about the program
- How vendor participation and claim timing requirements may affect practice workflows
- Why oncology and primary care stakeholders view the program as significant
Who Should Read This
- Physicians
- Oncology practices
- Medical coders
- Medical billers
- Practice administrators
- Compliance staff
- Healthcare reimbursement professionals
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com